Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Diagnostics
Sort By
Newest First
1 / 3
1 / 3
Neurology
The Next Frontier in Neurological Diagnostics and Therapeutics
Dave Rosa
NeuroOne
PAO-05-24-CL-02
May 30, 2024
Exosomes
Bright Outlook for Exosome-Based Therapeutics and Diagnostics Despite Numerous Hurdles
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-05-24-NI-01
May 09, 2024
Point of Care
Expanding Point-of-Care and CME Support for Clinicians
Casey Jenkins
epocrates
PAO-05-23-CL-05
May 03, 2023
Point of Care
Helping Clinicians Make Better Decisions More Easily
Matt Titus
epocrates
PAO-03-23-CL-05
March 16, 2023
Digital Health Solutions
Beyond Drug Sales: Adding Value with Digital Health
Gérard Klop; Marcos Gallego Llorente, Ph.D.
PAO-08-022-CL-05
September 28, 2022
Theranostics
Theranostic Manufacturing Solutions
Muctarr Sesay, Ph.D.
GBI
PAO-08-022-CL-07
August 29, 2022
Genomics
Connecting Genetic Mutations to Health
Heligenics
PAO-03-22-R250-12
March 21, 2022
Biosensors
Exploring Living Cells with Fluorescent Biosensors
Montana Molecular
PAO-03-22-R250-15
March 19, 2022
Cancer Diagnostics
Envisioning a New Cancer Diagnostic and Therapeutic Platform
Viewpoint Molecular Targeting, Inc.
PAO-02-22-R250-11
February 11, 2022
Series A Funding
Biofidelity Raises $23M in Series A+ Financing Led by Octopus Ventures to Launch ASPYRE Technology
Biofidelity
PR-M02-22-04
February 07, 2022
Diagnostic
GRAIL Introduces Galleri, a Groundbreaking Multi-Cancer Early Detection Blood Test
GRAIL
PR-M06-21-016
June 09, 2021
COVID-19 Diagnostic
FDA Authorizes First Single-Use, PCR Quality Over the Counter (OTC) LUCIRA CHECK IT™ COVID-19 At-Home Test. Available Now.
Lucira Health, Inc.
PR-M04-21-016-1029
April 16, 2021
Brain Cancer Diagnostics
Advancing Diagnostics to Address Brain Tumors
Dxcover
PAO-04-22-R221-16-538
April 09, 2021
Liquid Biopsy
FDA Approves First Liquid Biopsy Next-Generation Sequencing Companion Diagnostic Test
The FDA
PR-M08-20-NI-17
August 10, 2020
Diagnostic
New Rapid Molecular Test for Tuberculosis Can Simultaneously Detect Resistance to First- and Second-Line Drugs
Cepheid
PR-M07-20-NI-36
July 24, 2020
Coping with COVID-19
COVID-19: Understanding the Virus, the Pandemic, and the Path Forward
Cynthia A. Challener, Ph.D.; Emilie Branch; David Alvaro, Ph.D.
Pharma's Almanac
PAP-Q2-20-NI-004
July 01, 2020
COVID-19 Testing
The FDA Confirms Certain COVID-19 Serology and Antibody Tests Should Not Be Used
The FDA
PR-M06-20-NI-035
June 26, 2020
Partnership
Thermo Fisher Scientific to Co-develop a Global Companion Diagnostic for Low-grade Glioma with Agios Pharmaceuticals
Thermo Fisher Scientific
PR-M06-20-NI-023
June 18, 2020
Diagnostics
Cepheid Announces Development of Four-in-One Combination Test for SARS-CoV-2, Flu A, Flu B and RSV
Cepheid
PR-M06-20-NI-024
June 18, 2020
COVID-19 Test
FDA Authorizes First Standalone At-Home Sample Collection Kit That Can Be Used With Certain Authorized Tests
FDA
PR-M05-20-NI-026
May 18, 2020
